Publications

  1. Langer K, O'Shea DM, De Wit L, DeFeis B, Mejia A, Amofa P, Chandler M, Locke DEC, Locke D, Fields J, Phatak V, Dean PM, Smith G. Self-Efficacy Mediates the Association Between Physical Function and Perceived Quality of Life in Individuals with Mild Cognitive Impairment. J Alzheimers Dis. 2019; 68 (4):1511-1519
    View PubMed
  2. Caselli RJ, Langlais BT, Dueck AC, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Locke DEC. Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment. J Am Geriatr Soc. 2018 Apr; 66 (4):671-678 Epub 2018 Jan 17
    View PubMed
  3. Stonnington CM, Chen Y, Savage CR, Lee W, Bauer III, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, Reiman EM, Chen K. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. J Alzheimers Dis. 2018; 63 (2):603-615
    View PubMed
  4. Smith GE, Chandler M, Fields JA, Aakre J, Locke DEC. A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment. J Alzheimers Dis. 2018; 63 (4):1459-1468
    View PubMed
  5. Cuc AV, Locke DEC, Duncan N, Fields JA, Snyder CH, Hanna S, Lunde A, Smith GE, Chandler M. A pilot randomized trial of two cognitive rehabilitation interventions for mild cognitive impairment: caregiver outcomes. Int J Geriatr Psychiatry. 2017 Dec; 32 (12):e180-e187 Epub 2017 Feb 24
    View PubMed
  6. Smith G, Chandler M, Locke DE, Fields J, Phatak V, Crook J, Hanna S, Lunde A, Morris M, Graff-Radford M, Hughes CA, Lepore S, Cuc A, Caselli M, Hurst D, Wethe J, Francone A, Eilertsen J, Lucas P, Hoffman Snyder C, Kuang L, Becker M, Dean P, Diehl N, Lofquist M, Vanderhook S, Myles D, Cochran D. Behavioral Interventions to Prevent or Delay Dementia: Protocol for a Randomized Comparative Effectiveness Study. JMIR Res Protoc. 2017 Nov 27; 6 (11):e223
    View PubMed
  7. Stonnington CM, Harel B, Locke DEC, Hentz JG, Zhang N, Maruff P, Caselli RJ. Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease. Alzheimer Dis Assoc Disord. 2017 Oct-Dec; 31 (4):271-277
    View PubMed
  8. Chandler MJ, Locke DEC, Duncan NL, Hanna SM, Cuc AV, Fields JA, Hoffman Snyder CR, Lunde AM, Smith GE. Computer versus Compensatory Calendar Training in Individuals with Mild Cognitive Impairment: Functional Impact in a Pilot Study. Brain Sci. 2017 Sep 6; 7 (9) Epub 2017 Sept 06
    View PubMed
  9. Barrios PG, Gonzalez RP, Hanna SM, Lunde AM, Fields JA, Locke DE, Smith GE. Priority of Treatment Outcomes for Caregivers and Patients with Mild Cognitive Impairment: Preliminary Analyses. Neurol Ther. 2016 Dec; 5 (2):183-192 Epub 2016 Aug 09
    View PubMed
  10. Caselli RJ, Dueck AC, Locke DE, Henslin BR, Johnson TA, Woodruff BK, Hoffman-Snyder C, Geda YE. Impact of Personality on Cognitive Aging: A Prospective Cohort Study. J Int Neuropsychol Soc. 2016 Aug; 22 (7):765-76 Epub 2016 June 27
    View PubMed
  11. Shepard MA, Silva A, Starling AJ, Hoerth MT, Locke DE, Ziemba K, Chong CD, Schwedt TJ. Patients with psychogenic nonepileptic seizures report more severe migraine than patients with epilepsy. Seizure. 2016 Jan; 34:78-82.
    View PubMed
  12. Weissenbacher D, Johnson TA, Wojtulewicz L, Dueck A, Locke D, Caselli R, Gonzalez G. Automatic prediction of linguistic decline in writings of subjects with degenerative dementia. Proceedings of NAACL-HLT. 2016; 1198-1207.
  13. Krell-Roesch J, Woodruff BK, Acosta JI, Locke DE, Hentz JG, Stonnington CM, Stokin GB, Nagle C, Michel BF, Sambuchi N, Caselli RJ, Geda YE. APOE epsilon4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons. J Neuropsychiatry Clin Neurosci. 2015 Fall; 27 (4):322-5 Epub 2015 Mar 24
    View PubMed
  14. Wershba RE, Locke DE, Lanyon RI. Analysis of Minnesota Multiphasic Personality Inventory-2-Restructured Form response bias indicators as suppressors or moderators in a medical setting. Psychol Assess. 2015 Jun; 27 (2):733-7 Epub 2015 Mar 02
    View PubMed
  15. Lane RD, Hsu CH, Locke DE, Ritenbaugh C, Stonnington CM. Role of theory of mind in emotional awareness and alexithymia: Implications for conceptualization and measurement. Conscious Cogn. 2015 May; 33:398-405.
    View PubMed
  16. Wolf LD, Hentz JG, Ziemba KS, Kirlin KA, Noe KH, Hoerth MT, Crepeau AZ, Sirven JI, Drazkowski JF, Locke DE. Quality of life in psychogenic nonepileptic seizures and epilepsy: the role of somatization and alexithymia. Epilepsy Behav. 2015 Feb; 43:81-8 Epub 2015 Jan 05
    View PubMed
  17. Caselli RJ, Dueck AC, Locke DE, Baxter LC, Woodruff BK, Geda YE. Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct? J Int Neuropsychol Soc. 2015 Feb; 21 (2):95-104 Epub 2015 Feb 09
    View PubMed
  18. Locke DE, Greenaway MC, Duncan N, Fields JA, Cuc AV, Snyder CH, Hanna S, Lunde A, Smith GE. A patient-centered analysis of enrollment and retention in a randomized behavioral trial of two cognitive rehabilitation interventions for Mild Cognitive Impairment. J Prev Alzheimers Dis. 2014 Dec; 1 (3):143-150
    View PubMed
  19. Kirlin KA, Locke DEC. The role of neuropsychology on an epilepsy monitoring unit: A peek behind the "do not disturb" sign. The Neurodiagnostic Journal. 2014 Sep; 54(3):289-98.
    View PubMed
  20. Caselli RJ, Chen K, Locke DE, Lee W, Roontiva A, Bandy D, Fleisher AS, Reiman EM. Subjective cognitive decline: self and informant comparisons. Alzheimers Dement. 2014 Jan; 10 (1):93-8 Epub 2013 Apr 03
    View PubMed
  21. Stonnington CM, Chen K, Lee W, Locke DE, Dueck AC, Liu X, Roontiva A, Fleisher AS, Caselli RJ, Reiman EM. Fibrillar amyloid correlates of preclinical cognitive decline. Alzheimers Dement. 2014 Jan; 10 (1):e1-8 Epub 2013 Apr 11
    View PubMed
  22. Caselli RJ, Locke DE, Dueck AC, Knopman DS, Woodruff BK, Hoffman-Snyder C, Rademakers R, Fleisher AS, Reiman EM. The neuropsychology of normal aging and preclinical Alzheimer's disease. Alzheimers Dement. 2014 Jan; 10 (1):84-92 Epub 2013 Mar 26
    View PubMed
  23. Locke DE, Dueck AC, Stonnington CM, Knopman DS, Geda YE, Caselli RJ. Depressive symptoms in healthy apolipoprotein E epsilon4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry. 2013 Dec; 74 (12):1256-61
    View PubMed
  24. Stonnington CM, Locke DE, Hsu CH, Ritenbaugh C, Lane RD. Somatization is associated with deficits in affective Theory of Mind. J Psychosom Res. 2013 Jun; 74(6):479-85. Epub 2013 May 09.
    View PubMed
  25. Purdom CL, Kirlin KA, Hoerth MT, Noe KH, Drazkowski JF, Sirven JI, Locke DE. The influence of impression management scales on the Personality Assessment Inventory in the epilepsy monitoring unit. Epilepsy Behav. 2012 Dec; 25(4):534-8. Epub 2012 Nov 13.
    View PubMed
  26. Noe KH, Grade M, Stonnington CM, Driver-Dunckley E, Locke DE. Confirming psychogenic nonepileptic seizures with video-EEG: sex matters. Epilepsy Behav. 2012 Mar; 23(3):220-3. Epub 2012 Feb 15.
    View PubMed
  27. O'Carroll CB, Woodruff BK, Locke DE, Hoffman-Snyder CR, Wellik KE, Thaera GM, Demaerschalk BM, Wingerchuk DM. Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic. Neurologist. 2012 Jan; 18 (1):51-4
    View PubMed
  28. Locke DE, Stonnington CM, Thomas ML, Caselli RJ. Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging. J Clin Exp Neuropsychol. 2011 Oct; 33 (8):937-43 Epub 2011 June 27
    View PubMed
  29. Locke DE, Kirlin KA, Wershba R, Osborne D, Drazkowski JF, Sirven JI, Noe KH. Randomized comparison of the Personality Assessment Inventory and the Minnesota Multiphasic Personality Inventory-2 in the epilepsy monitoring unit. Epilepsy Behav. 2011 Aug; 21(4):397-401. Epub 2011 Jul 06.
    View PubMed
  30. Noe KH, Locke DE, Sirven JI. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol. 2011 Aug; 13(4):371-9.
    View PubMed
  31. Driver-Dunckley E, Stonnington CM, Locke DE, Noe K. Comparison of psychogenic movement disorders and psychogenic nonepileptic seizures: is phenotype clinically important? Psychosomatics. 2011 Jul-Aug; 52(4):337-45. Epub 2011 Jun 08.
    View PubMed
  32. Stonnington CM, Locke DE, Dueck AC, Caselli RJ. Anxiety affects cognition differently in healthy apolipoprotein E epsilon4 homozygotes and non-carriers. J Neuropsychiatry Clin Neurosci. 2011 Summer; 23(3):294-9.
    View PubMed
  33. Caselli RJ, Dueck AC, Locke DE, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM. Longitudinal modeling of frontal cognition in APOE epsilon4 homozygotes, heterozygotes, and noncarriers. Neurology. 2011 Apr 19; 76 (16):1383-8
    View PubMed
  34. Caselli RJ, Dueck AC, Locke DE, Sabbagh MN, Ahern GL, Rapcsak SZ, Baxter LC, Yaari R, Woodruff BK, Hoffman-Snyder C, Rademakers R, Findley S, Reiman EM. Cerebrovascular risk factors and preclinical memory decline in healthy APOE epsilon4 homozygotes. Neurology. 2011 Mar 22; 76 (12):1078-84 Epub 2011 Feb 16
    View PubMed
  35. Locke DE, Thomas ML. Initial development of Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) scales to identify patients with psychogenic nonepileptic seizures. J Clin Exp Neuropsychol. 2011 Mar; 33(3):335-43. Epub 2010 Nov 10.
    View PubMed
  36. Powell MR, Locke DE, Smigielski JS, McCrea M. Estimating the diagnostic value of the trail making test for suboptimal effort in acquired brain injury rehabilitation patients. Clin Neuropsychol. 2011 Jan; 25(1):108-18. Epub 2010 Nov 23.
    View PubMed
  37. Thomas ML, Locke DE. Psychometric properties of the MMPI-2-RF Somatic Complaints (RC1) scale. Psychol Assess. 2010 Sep; 22(3):492-503.
    View PubMed
  38. Hurst DF, Locke DE, Osborne D. Evaluation of potential kidney donors with the personality assessment inventory: normative data for a unique population. J Clin Psychol Med Settings. 2010 Sep; 17 (3):183-94
    View PubMed
  39. Locke DE, Kirlin KA, Thomas ML, Osborne D, Hurst DF, Drazkowski JF, Sirven JI, Noe KH. The Minnesota Multiphasic Personality Inventory-2-Restructured Form in the epilepsy monitoring unit. Epilepsy Behav. 2010 Feb; 17(2):252-8. Epub 2010 Jan 12.
    View PubMed
  40. Locke DE, Fakhoury TA, Berry DT, Locke TR, Schmitt FA. Objective evaluation of personality and psychopathology in temporal lobe versus extratemporal lobe epilepsy. Epilepsy Behav. 2010 Feb; 17(2):172-7. Epub 2009 Dec 22.
    View PubMed
  41. Lageman SK, Cerhan JH, Locke DE, Anderson SK, Locke DE, Wu W, Brown PD. Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trials. J Neurooncol. 2010 Jan; 96 (2):271-6 Epub 2009 July 19
    View PubMed
  42. Stonnington CM, Driver-Dunckley ED, Noe KH, Locke DEC. Conversion and somatization disorders. BMJ Best Practice 2009 accessible on epocrates.com. Available at: www.bestpractice.bmj.com (updated annually). 2009 Sep.
  43. Caselli RJ, Dueck AC, Osborne D, Sabbagh MN, Connor DJ, Ahern GL, Baxter LC, Rapcsak SZ, Shi J, Woodruff BK, Locke DE, Snyder CH, Alexander GE, Rademakers R, Reiman EM. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med. 2009 Jul 16; 361 (3):255-63
    View PubMed
  44. Locke DE, Dassel KB, Hall G, Baxter LC, Woodruff BK, Hoffman Snyder C, Miller BL, Caselli RJ. Assessment of patient and caregiver experiences of dementia-related symptoms: development of the Multidimensional Assessment of Neurodegenerative Symptoms questionnaire. Dement Geriatr Cogn Disord. 2009; 27 (3):260-72 Epub 2009 Feb 25
    View PubMed
  45. Locke DE, Ivnik RJ, Cha RH, Knopman DS, Tangalos EG, Boeve BF, Petersen RC, Smith GE. Age, family history, and memory and future risk for cognitive impairment. J Clin Exp Neuropsychol. 2009 Jan; 31 (1):111-6 Epub 2008 May 16
    View PubMed
  46. Locke DE, Cerhan JH, Wu W, Malec JF, Clark MM, Rummans TA, Brown PD. Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: a pilot study. J Support Oncol. 2008 Nov-Dec; 6(8):383-91.
    View PubMed
  47. Kean J, Locke DE. Neuropsychological consequences of cancer and cancer treatment. Perspectives on Neurophysiological and Neurogenic Speech and Language Disorders. 2008; 18:144-51.
  48. Locke DE, Smigielski JS, Powell MR, Stevens SR. Effort issues in post-acute outpatient acquired brain injury rehabilitation seekers. NeuroRehabilitation. 2008; 23: (3)273-81.
    View PubMed
  49. Locke DE, Decker PA, Sloan JA, Brown PD, Malec JF, Clark MM, Rummans TA, Ballman KV, Schaefer PL, Buckner JC. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage. 2007 Dec; 34 (6):628-38 Epub 2007 Aug 20
    View PubMed
  50. Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol. 2007 Sep; 64(9):1306-11.
    View PubMed
  51. Cragar DE, Berry DT, Fakhoury TA, Cibula JE, Schmitt FA. Performance of patients with epilepsy or psychogenic non-epileptic seizures on four measures of effort. Clin Neuropsychol. 2006 Sep; 20(3):552-66.
    View PubMed
  52. Locke DE, Berry DT, Fakhoury TA, Schmitt FA. Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures. J Clin Exp Neuropsychol. 2006 Apr; 28(3):325-40.
    View PubMed
  53. Cragar DE, Berry DT, Schmitt FA, Fakhoury TA. Cluster analysis of normal personality traits in patients with psychogenic nonepileptic seizures. Epilepsy Behav. 2005 Jun; 6(4):593-600.
    View PubMed
  54. Dearth CS, Berry DT, Vickery CD, Vagnini VL, Baser RE, Orey SA, Cragar DE. Detection of feigned head injury symptoms on the MMPI-2 in head injured patients and community controls. Arch Clin Neuropsychol. 2005 Jan; 20(1):95-110.
    View PubMed
  55. Vickery CD, Berry DT, Dearth CS, Vagnini VL, Baser RE, Cragar DE, Orey SA. Head injury and the ability to feign neuropsychological deficits. Arch Clin Neuropsychol. 2004 Jan; 19(1):37-48.
    View PubMed
  56. Cragar DE, Schmitt FA, Berry DT, Cibula JE, Dearth CM, Fakhoury TA. A comparison of MMPI-2 decision rules in the diagnosis of nonepileptic seizures. J Clin Exp Neuropsychol. 2003 Sep; 25(6):793-804.
    View PubMed
  57. Cragar DE, Horvath LS. Application of social skills training to a child with Asperger's Disorder. Clinical Case Studies. 2003; 2:34-49.
  58. Cragar DE, Berry DT, Fakhoury TA, Cibula JE, Schmitt FA. A review of diagnostic techniques in the differential diagnosis of epileptic and nonepileptic seizures. Neuropsychol Rev. 2002 Mar; 12(1):31-64.
    View PubMed
  59. Schmitt FA, Cragar D, Ashford JW, Reisberg B, Ferris S, Mobius HJ, Stoffler A. Measuring cognition in advanced Alzheimer's disease for clinical trials. J Neural Transm Suppl. 2002(62):135-48.
    View PubMed
  60. Orey SA, Cragar DE, Berry DT. The effects of two motivational manipulations on the neuropsychological performance of mildly head-injured college students. Arch Clin Neuropsychol. 2000 May; 15(4):335-48.
    View PubMed